7c22 Citations

Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein.

Mol Biomed 1 2 (2020)
Cited: 26 times
EuropePMC logo PMID: 35006385

Abstract

The newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global human health crisis. The CoV nucleocapsid (N) protein plays essential roles both in the viral genomic RNA packaging and the regulation of host cellular machinery. Here, to contribute to the structural information of the N protein, we describe the 2.0 Å crystal structure of the SARS-CoV-2 N protein C-terminal domain (N-CTD). The structure indicates an extensive interaction dimer in a domain-swapped manner. The interface of this dimer was first thoroughly illustrated. Also, the SARS-CoV-2 N-CTD dimerization form was verified in solution using size-exclusion chromatography. Based on the structural comparison of the N-CTDs from alpha-, beta-, and gamma-CoVs, we demonstrate the common and specific characteristics of the SARS-CoV-2 N-CTD. Furthermore, we provide evidence that the SARS-CoV-2 N-CTD possesses the binding ability to single-stranded RNA, single-stranded DNA as well as double-stranded DNA in vitro. In conclusion, this study could potentially accelerate research to understand the complete biological functions of the new CoV N protein.

Reviews - 7c22 mentioned but not cited (7)

  1. A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19. Saied EM, El-Maradny YA, Osman AA, Darwish AMG, Abo Nahas HH, Niedbała G, Piekutowska M, Abdel-Rahman MA, Balbool BA, Abdel-Azeem AM. Pharmaceutics 13 1759 (2021)
  2. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery. Chellapandi P, Saranya S. Med Chem Res 29 1777-1791 (2020)
  3. The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies. Waman VP, Sen N, Varadi M, Daina A, Wodak SJ, Zoete V, Velankar S, Orengo C. Brief Bioinform 22 742-768 (2021)
  4. Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility. Matsuo T. Biology (Basel) 10 454 (2021)
  5. SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development. Kaur M, Sharma A, Kumar S, Singh G, Barnwal RP. Int J Biol Macromol 179 45-60 (2021)
  6. Principles and functions of condensate modifying drugs. Patel A, Mitrea D, Namasivayam V, Murcko MA, Wagner M, Klein IA. Front Mol Biosci 9 1007744 (2022)
  7. Overview of Nucleocapsid-Targeting Vaccines against COVID-19. Rak A, Isakova-Sivak I, Rudenko L. Vaccines (Basel) 11 1810 (2023)

Articles - 7c22 mentioned but not cited (19)